ScanGrants is a public service listing of grants and other funding types to support health research, programs and scholarship.
20 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
Sjögren’s Syndrome Foundation Research Grants Program
The Sjögren’s Syndrome Foundation strives to foster research that will have the greatest potential impact on Sjögren’s patients, ensuring new therapeutics are developed and a cure found.
One important way in which we strive for change is to promote innovative research that will have the greatest impact on the lives of those who have this prevalent and devastating disease. We want to help spur the research community to generate fresh ideas that will bring novel approaches to treatment and the development of new therapeutics and lead to a cure. The SSF currently focuses on many initiatives to reach this goal, including: the development of Clinical Practice Guidelines, the launching of a Clinical Trials Consortium, advocacy among federal research entities, and through the SSF Research Grants Program.
The SSF Research Grants Program places a high priority on both clinical and basic scientific research into the cause, prevention, detection, treatment, and cure of Sjögren’s, with support provided to investigators at every career level from student to junior investigator to senior-level leader.
SSF Research Funding Priorities
Innovation is key for all SSF research funding. We must inspire new ideas and the gathering of data necessary to determine if those ideas are viable so that investigators can take a risk to pursue a concept that could prove to be a major breakthrough in Sjögren’s.
Funding decisions for SSF grants will be based on the following priorities:
• Innovative and creative concepts
• Novel diagnostics and relevance to the SSF Breakthrough Goal
• Direct relevance to Sjögren’s
• High quality science
• Preliminary data; probability of SSF seed money leading to an NIH grant
• Potential practical importance through the use of human tissues or blood samples
• Outcome could define new therapeutic target in SS
• Collaborative aspects of project
• Focused and achievable in the time lines
• Author on peer-reviewed articles
• A young investigator who has already displayed a productive commitment to SS research and a potential career in the field
• Letters of recommendation (if required) praise commitment, focus, high standards and excellence Financial support important for the salary support and execution of the research
•Excellent lab environment and mentorship available if young investigator
Grants will be awarded in amounts ranging between $15,000 and $50,000 a year for two years, depending on satisfactory progress. A human study that reviewers deem to be the most innovative project will be eligible for a $50,000 grant. All investigators will submit a budget for$35,000 and revise the budget once an award offer is accepted.
SSF research grants are open to basic and clinical scientists holding an advanced degree (MD, DDS, DMD, or PhD) at any U.S. university or research institution. Both junior and senior investigators may apply. For physicians, advanced clinical training in a specialty related to Sjögren’s, such as rheumatology or ophthalmology, is desirable.
The application receipt deadline is February 1, 2015. The grant funding period is July 1 through June 30.
Sjögren's Syndrome Foundation
6707 Democracy Boulevard
Bethesda, MD 20817
Toll Free: (800) 475-6473
Local call: (301) 530-4420
Fax: (301) 530-4415
FSH Society Research Grants and Fellowships
We are the world's largest and most progressive grassroots network of facioscapulohumeral muscular dystrophy (FSHD) patients, their families and research activists. The FSH Society harnesses the power and insight of a patient-driven model, as it was founded on a promise between two research scientists with FSHD never to let the disease be forgotten or neglected. We are a cause without borders.
FSH Society research and fellowship grant awards provide vital start-up funding for investigators in FSHD and research projects on FSHD. The research milestones and insights gained are demonstrably significant.
The fellowship program allows innovative and entrepreneurial research to develop and ultimately to be able to attract funding from large funding sources such as the US National Institutes of Health (NIH). The FSH Society meets an important need in funding and developing new ideas and supporting new investigators in FSHD research by giving them the funds needed to develop data and to carry their ideas to the next stage of development. Without the FSH Society research and fellowships program, many key initiatives in FSHD research might never have had the chance to begin. Well over 300 peer-reviewed papers have been published by FSH Society-funded researchers.
Since 1998, the FSH Society has transformed FSHD research. The field is on the verge of significant breakthroughs. It is essential to fund new ideas and support new investigators and new lines of investigation when tackling a disease as complex as FSHD.
Deadlines for receipt of grant, research fellowship and postdoctoral fellowship applications are February 28/29 and August 31 of each year.
CurePSP Grants Program
CurePSP has always believed that truly effective clinical interventions will follow good, solid basic scientific research. For this reason, CurePSP promotes research that helps generate an integrated picture of PSP and CBD at the molecular and cellular levels. CurePSP believes that in the long term, research of this nature will prove indispensable in developing a prevention or cure for PSP and CBD.
CurePSP has carefully structured its research program and has identified the programs that have been the most successful and those that need strengthening. With an increased research budget made possible through improved donor support, CurePSP will be able to markedly intensify the efforts to cure the disease in a way that promises relief for those afflicted today as well as hope for those who may be afflicted tomorrow.
Investigator-Initiated Research Projects
CurePSP accepts proposals for research projects by other investigators. CurePSP's Scientific Advisory Board reviews all submissions and recommends the most appropriate ones for funding. Details surrounding the submission of grants are as follows:
Grant application deadlines are quarterly on January 15, April 15, July 15, and October 15
Applicants will be notified when the grant is received by CurePSP
The Scientific Advisory Board will submit recommendations for funding at CurePSP's quarterly Board of Directors meeting
The maximum total grant amount awarded is $100,000. The period of the grant may be up to 3 years in duration but the total cannot exceed $100,000. However, greater or lesser amounts and durations may be offered depending on resources available
Any investigators interested in submitting a grant application should first review CurePSP's Research Policies and Procedures.
Friedreich's Ataxia Research Alliance General Research Grant
FARA accepts LOIs from qualified investigators for projects that target FARA’s research priorities twice per year (due February 1 and July 15).
For those invited to submit a full application, the deadlines for submission are April 1 and September 15, respectively.
On the Main Grant Page, put “General Research” in the “Grant Type” field.
The applicant may request a budget of up to $150,000 per year for one or two years.
General Research Grant Subtype:
Postdoctoral Trainees and Ph.D. Students
Salaries for all those contributing to the research project (PI, postdocs, graduate students, research associates, etc.) can be requested under personnel costs in the budget of a General Research Grant application.
Additionally, FARA has an application subtype specifically for PIs requesting only salary (plus applicable benefits) to support postdoctoral trainees and Ph.D. students in their laboratory. The PI is encouraged to involve the trainee/student in the preparation of the research plan to be submitted with the application. The name and CV of the postdoctoral trainee or Ph.D. student must be included in the application.
The guidelines for General Research Grants should be followed, but the only allowable budget item is salary for the postdoctoral trainee or Ph.D. student (plus applicable benefits and tuition support) and the requested amount must not exceed the appropriate NIH stipend level.
Bronya J. Keats Award for International Collaboration in Research on Friedreich's Ataxia
FARA accepts LOIs focusing on FA research that relies on international collaboration among investigators in at least two different countries. Special consideration will be given to proposals that bring new scientists to the FA community. The rationale for the collaboration needs to be convincing and must clearly demonstrate that the research goals could not be achieved by just one of the participating groups and that the synergy among the groups is essential for the success of the project.
The deadline for the LOI is May 15. For those invited to submit a full application, the deadline for submission is July 15.
On the Main Grant Page, put “Keats Award” in the “Grant Type” field. The applicants may request a combined budget of up to $200,000 per year for one or two years.
Friedreich's Ataxia Research Alliance Phillip Bennett and Kyle Bryant Translational Research Award
FARA accepts LOIs focusing on pre-clinical and clinical investigations that will advance treatments for FA.
The specific aims must target one or more of the following:
Identification of biomarkers for FA that will elucidate disease variability, severity, and prognosis; facilitate drug screening, and/or optimize selection of patients and clinical endpoints for clinical trials;
Development of tools and technologies that can (a) be directly used for therapy development; (b) overcome existing obstacles to treatment and (c) be directly applied to, or adapted for, delivery of potential therapeutics;
Pre-clinical development and testing of potential therapeutics, biologics, and devices in cells and animals;
Clinical studies of patient outcome measures, potential interventions, or devices.
The deadline for the LOI is May 15. For those invited to submit a full application, the deadline for submission is July 15. On the Main Grant Page, put “PB and KB Translational Award” in the “Grant Type” field. The applicant may request a budget of up to $250,000 per year for one or two years.
Muscular Dystrophy Association Research Grants Programs
MDA supports research aimed at developing treatments for the muscular dystrophies and related diseases of the neuromuscular system. These are the muscular dystrophies (among which are Duchenne and Becker); motor neuron diseases (including ALS and SMA); the peripheral nerve disorders (CMT and Friedreich's ataxia); inflammatory myopathies; disorders of the neuromuscular junction; metabolic diseases of muscle as well as other myopathies.
To be eligible to apply for an MDA research grant, an applicant must:
Hold a Doctor of Medicine (M.D.), Doctor of Philosophy (Ph.D.), Doctor of Science (D.Sc.) or equivalent degree (i.e. D.O.);
Be a professional or faculty member (Professor, Associate Professor or Assistant Professor) at an appropriate educational, medical or research institution;
Be qualified to conduct and mentor a program of original research within his or her own laboratory;
Assume both administrative and financial responsibility for the grant; and
Have access to institutional resources necessary to conduct the proposed research project.
Proposals from applicants outside the United States will be considered for projects of highest priority to MDA and when, in addition to the applicant's having met the requirements noted above, the applicant's country of residence may not have adequate sources of financial support for biomedical research.
NOTE: To apply for a Research Grant, you must be an independent investigator, i.e., not a trainee, not a post-doctoral fellow, not a research assistant, not a research associate and not under the supervision of another person (Principal Investigator/Independent Investigator) who is directing the research.
MDA will consider an application for a research development grant from a candidate who may be a member of a research team in the laboratory of an independent investigator (Principal Investigator) under whose guidance the applicant will be given flexibility to conduct a neuromuscular disease research project.
To be eligible for a Development Grant, an applicant must:
Be a member of a research team at an appropriate institution;
Be qualified to conduct a program of original research under the supervision of a Principal Investigator;
Have an acceptable research plan for a specific disease in MDA's program;
Have access to institutional resources necessary to conduct the proposed research project;
Have a minimum of eighteen (18) months of post-degree research laboratory training at the time of application;
Be no more than 60 months from receiving their most recent advanced degree (e.g. PhD, MD or equivalent); and
Not have been funded under the Development Grant program in the past.
Awards are for either one, two or three years for all grant types.
Funding levels for primary Research Grants are unlimited. Development grants are a maximum of $60,000 per year. Overhead is limited to a maximum of 10% percent of direct costs to be included in the total amount of the grant request.
A pre-proposal form must be submitted through proposalCENTRAL to formally request an application for an MDA research grant. Requests for applications can be submitted anytime prior to the applicable deadline date.
Applications are not open to institutions for general distribution.
ONLY TWO GRANT REVIEW ROUNDS ARE HELD EACH YEAR.
ONLY ONE "LETTER OF INTENT" IS PERMITTED PER GRANT REVIEW ROUND.
Letter of Intent: December 15
Letter of Intent: June 15
Muscular Dystrophy Association
Grants Manager - Research Department
3300 E. Sunrise Drive
Tucson, AZ 85718
(520) 529-5454 (fax)
Call for Applications: Marfan Foundation Faculty Grant Program
The faculty grant program supports two-year grants for basic or clinical research for all disciplines in Marfan syndrome and related disorders.
Our Scientific Advisory Board evaluates proposals and award grants with the approval of our Board of Directors.
We co-fund one two-year grant for $100,000 with the Canadian Marfan Association. The Canadian Marfan Association funding is provided by the Temerty Family Foundation.
We award an additional one or two-year $100,000.
The principal investigator must hold an MD, DO, PhD, ScD, DDS, DVM, or equivalent degree.
The investigator must have proven ability to pursue independent research as evidenced by original research publications in peer-reviewed journals and hold a position of Associate Professor or above.
Work can be performed in the U.S. or internationally.
Applications must be submitted via our website.
Application Deadline: April 27, 2014
Award Announcement: October 1, 2014
Funds Available: January 1, 2015
National Ataxia Foundation Research Grants
Research Grant: One-year seed money grants of up to $15,000 but promising proposals up to a maximum of $30,000 will be considered for early or pilot phases of studies and ongoing investigations.
July 15, 2014 - Date the Letter of Intent is due with a ½ to one-page abstract with specific aims of your research.
August 15, 2014 - Full application due
Email all correspondence and questions to Sue Hagen at email@example.com. Please include the last name of the principal investigator as the first word in the subject line of any email you send.
For the Research, Young Investigator and Research Post-Doc Fellowship Awards, the number of grants awarded is dependent upon funds available. In 2013 46 research applications in those three grant programs were submitted. NAF was able to fund 16 of those grants.
National Ataxia Foundation Young Investigator Awards
Young Investigator (YI) Award: One-year grants* of $35,000 to encourage young investigators to pursue a career in the field of any form of ataxia research.
Young Investigator (YI-SCA) Award for SCA Research: One-year grants of $50,000 will be awarded to encourage young investigators to pursue a career in spinocerebellar ataxia (SCA) research.
For both Young Investigator award programs, candidates must have attained an MD or PhD degree, and have an appointment as a junior faculty member, senior post-doc or clinical fellow. Individuals at the Associate Professor level are not eligible. Clinicians must have finished their residency no more than five years prior to applying. PhDs must be no more than five years from end of the completion of their post-doc training.
The sponsoring institution must agree in writing to the following provision: the young investigator (MD or PhD) must be free to allocate approximately half time (50%) for ataxia related research.
August 1, 2014 – Date the Letter of Intent is due with a ½ to one-page abstract with specific aims of your research
September 2, 2014 - Full application due
*For the Research, Young Investigator and Research Post-Doc Fellowship Awards, the number of grants awarded is dependent upon funds available. In 2013 46 research applications in those three grant programs were submitted. NAF was able to fund 16 of those grants.